Physician profile
Quan Ma
NPI 1417152430
$4,297.07
in general payments reported to CMS, 2019-2025
9 companies · $34.70 in 2025
The $34.70 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,551 · 2021: $653 · 2022: $1,400 · 2023: $581 · 2024: $76.81 · 2025: $34.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $457 · Food and Beverage: $172 · Gift: $33.70 · Education: $29.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $457.00 |
| Food and Beverage | $172.44 |
| Gift | $33.70 |
| Education | $29.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $1,986.25 | 2019-2023 | |
| Dentsply Sirona INC | $1,404.38 | 2021-2025 | Astra Tech Implant System, Suresmile |
| Sirona Dental, INC. | $750.00 | 2019 | |
| 3m Company | $58.40 | 2019-2023 | Scotchbond Universal Plus, 3m Espe Filtek Supreme Ultra Universal Restorative |
| A-Dec, INC. | $33.70 | 2023 | |
| Kerr Corporation | $19.92 | 2023 | Harmonize |
| Nobel Biocare USA | $19.92 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $14.05 | 2019 | |
| Align Technology, INC. | $10.45 | 2024 | Invisalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quan Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.